The field of sarcoma study is getting more specific, with clinical investigations drilling down to more specific subtypes of soft tissue sarcoma for better targeted therapies. Our discussion with ...

Sarcomas are a heterogeneous group of rare cancers, with more than 70 distinct histologic subtypes 1, making treatment response and recurrence especially difficult to monitor through standard imaging ...

CHICAGO – An artificial intelligence (AI)-based model accurately classified pediatric sarcomas using digital pathology images alone, according to results presented at the American Association for ...

Novel biomarkers like GDF15 and OPN show promise in diagnosing and prognosticating uterine sarcoma, potentially enabling early identification and tailored therapy. Blood-based markers such as NLR and ...

Los Angeles-based UCLA Health has amassed the largest collection of sarcoma patient-derived tumor organoids to date, allowing researchers to study and replicate tumor response to drug therapies, ...

Uterine sarcomas are rare mesenchymal tumors that are aggressive cancers. The rarity of these tumors, and consequently limited prospective data, has made surgical management of uterine sarcomas ...

Highlighting the urgent need for awareness and support for sarcoma, a rarely discussed but serious cancer affecting many.

NORFOLK, Va. (WAVY) — Sarcoma, one of the rarest cancers in the world, makes up just 1% of all adult cancer diagnoses, but it is widely recognized as the ‘forgotten cancer,’ putting emphasis on just ...

In patients with mostly undifferentiated pleomorphic sarcomas, 2-year DFS with the addition of preoperative and postoperative pembrolizumab (Keytruda) infusions reached 67%, as compared with 52% with ...

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer Safety and Tolerability of ...

Stanford-led study included over 2,100 Signatera samples from over 200 sarcoma patients, with overall sensitivity of 89% and specificity of 100% Leiomyosarcoma, the most common subtype in the cohort, ...